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Results: Patients affected by congestive heart failure (CHF) have high plasmatic levels o f  
Arginine vasopressin even though they are hypervolemic with lower plasma osmolarity and serum 
sodium levels and this happens because o f  the lower effective o f  arterial blood volume, decreased 
cardiac output and Angiotensin II-induced AVP release. Arginine vasopressin exerts adverse effects in 
CHF by increasing vascular peripheric resistance via V ia  Receptors and by enhancing water retention 
through V2 Receptors from renal collecting tubules. Furthermore, sustained stimulation o f  V laR  in the 
heart can lead to remodeling by stimulating cell hypertrophy and further deteriorates cardiac function. 
Therefore, blockade o f  the AVP system may prove as a useful adjunct or alternative tostandard therapy 
in CHF. Currently there are 4 major compounds which are AVP-antagonists, 3 o f  them are selective 
antagonists o f  V2R: Tolvaptan, Satavaptan and Lixivaptan and 1 is a nonselective antagonist o f  V laR  
and V2R: Conivaptan. Only Conivaptan and Tolvaptan are approved by FDA, the first one for treating 
hypervolemic and euvolemic hyponatremia and the second one for the treatment o f  CHF, liver cirrhosis 
and SIADH (syndrome o f  inappropriate antidiuretic hormone secretion).
Conclusion: According to the results o f the clinical trials that were mentioned above, this new class o f 
medicines is efficient in short-term regulation o f hyponatremia and hypervolemia in congestive heart failure 
and may be used as an alternative for patients with resistance to diuretics. Long-term efficiency wasn’t 
demonstrated and there are many questions that have to be elucidated regarding to this class o f drugs.
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Introduction: Henoch-Schoenlein Purpura is the most frequent vasculitis in pediatric patients 
usually with a self-limiting evolution. Still the evolution o f  the disease is hardly predictable with a 
possibility to acquire a severe clinical form. This paper had the goal to highlight the possible correlation 
between the severity o f  the degree o f  the histopathological lesions and the expression o f markers o f  
endothelial status and cellular and humoral immune status. Other researches with similar purpose were 
performed, but the analysis o f  the literature has shown that the results are contradictory.
Materials and Methods: To reach the goal, we have performed histopathological diagnosis 
and analysis o f  skin biopsies and we have evaluated the endothelial status, cellular immune status 
and humoral immune status.
Results: We founded a significant correlation between the degree o f  implication o f  
microcirculation and the level o f  markers o f  the endothelial status.
Conclusions: The markers o f  the endothelial activation can be an alternative method in evaluation 
o f the severity o f  disease and therefore o f the therapeutical strategy, still more researches are necessary.
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Introduction: Polycystic ovary syndrome (PCOS) is a heterogeneous multifactorial disease 
characterized by menstrual disorders, chronic anovulation, hyperandrogen ism, cystic changes in the 
ovaries and infertility. The syndrome is a condition with prepubertal onset, affecting especially 
women o f  childbearing age.
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Objectives o f  the study were to elucidate the main etiopathogenic mechanisms, the criteria 
for diagnosis o f metabolic changes and the most common complications in PCOS.
Materials and Methods: Relevant scientific articles regarding PCOS from medical databases 
were analyzed.
Results: The frequency o f PCOS is estimated at 0.6-11% among gynecological diseases. 
PCOS is found in 1.5-20% women o f childbearing age, 50-75% -  with anovulatory infertility and 
30-40% -  with amenorrhea. Etiopathogenesis o f PCOS remains unknown despite multiple studies. 
Decreased peripheral insulin sensitivity and consequently hyperinsulinemia are considered prim ary 
factors in the pathogenesis o f PCOS. Insulin resistance and hyperinsulinemia are largely found 
laboratory symptoms o f  PCOS, insulin resistance being indentified in 25% o f  middle-aged 
pacients. Thyroid disorders also are frecuently accompaning PCOS, highlightening the link between 
PCOS and autoimmune thyroiditis, rising concern that female hormones may play a role in 
triggering these diseases. O f all cases o f  thyroid pathology there were an increased frequency o f  
cases o f goiter (49.2%) and autoimmune thyroiditis (41.3%). Metabolic m anifestations o f  
hyperandrogenism were identified in PCOS: 42.8% o f  the patients had increased levels o f  plasma 
testosterone with normal urine excretion o f 17-CS, 28 .6% - th e  increase in both plasma testosterone 
as well as 17-CS excretion. In 14.3% o f patients ovarian hyperandrogenia genesis was demonstrated 
only by applying the test with dexamethasone and chorionic gonadotropin, while in 9.5% o f  patients 
hyperandrogenia could not be demonstrated by hormone investigations. In 30% o f  cases PCOS was 
accompaned by secondary hyperprolactinemia.
Conclusion: Based on available literature data polycystic ovarian syndrome may be defined by the 
presence o f hyperandrogenic (clinical and/or biochemical) and ovarian (oligo-, anovulation and/or 
polycystic ovaries) disorders. The main metabolic symptoms o f  PCOS are hyperandrogenism, 
hyperinsulinemia with insulin resistance, hypo- and hyperthyroidism and secondary hyperprolactinemia. 
Most common complications are impaired glucose tolerance and type II diabetes, cardiovascular disorders 
(dyslipidemia, hypertension, coronary heart disease) and risk o f abortion or premature birth.
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Introduction: The heart is the engine o f  the body, being one o f  the main organs o f  the human 
body, placed in the median region o f thorax. The heart is placed in the centre o f  the circulatory 
system, being a muscular organ which pumps blood in the human body. The circulatory system 
consists o f arteries, veins and capillaries, which carry the blood from and to body regions.
Purpose and Objectives: To understand the great importance o f  the heart at clinical level and 
to apply the topographic anatomical knowledge about the vascularization and innervation o f  the 
heart and the influence o f some muscule formation on the heart.
Results: The heart is the central organ o f the cardiovascular system. It is situated in the mediastinum 
and has a triangular pyramid or a flattened cone shape, placed on the diaphragm. The heart axis is directed 
obliquely downward, toward the left. The heart wall is made o f 3 layers, each one consisting o f  some nervo- 
vascular formations. They are o f great importance. Arterial vascularization is provided by the coronary 
arteries, which originate in the right and left aortic sinuses. The big coronary arteries run on the surface o f  the 
the heart and give subendocardial branches. The irigation o f the heart is made in diastole. The coronary 
arteries are classified as “end circulation”, with little anostomoses between branches. The heart 
vascularization scheme: The right coronary artery: the inferior and posterior wall o f  the left ventricle, 1/2 
posterior o f the septum, the side wall o f the right ventricle. Circumflex artery: the side wall o f the the left
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